These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004212-23 Randomized study with oral tegafur versus capecitabina in the treatment of advanced politreated breast cancer and refractory, resistant or in progression to the standard chemotherapeutic treatment not-yet-due
Ongoing 2005-003814-14 Pharmacodynamic study of Erlotinib (Tarceva) in patients with mestastatic or locally advanced Epidermoid carcinoma of the head and neck not-yet-due
Ongoing 2005-005738-11 Phase II Study of Single Agent RAD001 in Patients with Colon Cancer and Activating Mutations in the PI3KCA gene. not-yet-due
Ongoing 2005-006171-12 Estudio del tratamiento combinado, en primera línea, de capecitabina administrada de forma continua, oxaliplatino y bevacizumab administrado bisemanalmente en pacientes con adenocarcinoma colorrectal... not-yet-due